LifeSci Capital Maintains Inventiva(IVA.US) With Buy Rating, Maintains Target Price $14

robot
Abstract generation in progress

LifeSci Capital analyst Rami Katkhuda has reiterated a Buy rating for Inventiva (IVA.US) and maintained a target price of $14. According to TipRanks data, Katkhuda has a 53.8% success rate and an average return of 32.0% over the past year. This report highlights the analyst’s continued positive outlook on Inventiva’s stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin